G01N 2800/22
Haematology
G01N2800/22 (Haematology) appears on 345 US grants and 660 published applications in this corpus.
Search patents in G01N- Granted patents
- 345
- Published applications
- 660
- Assignees
- 386
- Inventors
- 1,281
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 6 |
| 2003 | 3 | 7 |
| 2004 | 1 | 3 |
| 2005 | 1 | 2 |
| 2006 | 2 | 19 |
| 2007 | 5 | 16 |
| 2008 | 3 | 13 |
| 2009 | 4 | 19 |
| 2010 | 3 | 33 |
| 2011 | 12 | 26 |
| 2012 | 9 | 26 |
| 2013 | 16 | 29 |
| 2014 | 20 | 23 |
| 2015 | 24 | 59 |
| 2016 | 23 | 57 |
| 2017 | 24 | 38 |
| 2018 | 33 | 36 |
| 2019 | 19 | 31 |
| 2020 | 24 | 25 |
| 2021 | 27 | 35 |
| 2022 | 19 | 45 |
| 2023 | 13 | 27 |
| 2024 | 18 | 38 |
| 2025 | 21 | 31 |
| 2026 | 10 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- System for determining an underlying cause of anemia25 Aug 2026US 12,716,900 B2Quest Diagnostics Investments Incorporated
- Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method23 Jun 2026US 12,663,429 B2C A Casyso GmbH
- Clinical decision support system16 Jun 2026US 12,656,333 B2Instrumentation Laboratory Company
- Apparatus and method to determine stroke subtype21 Apr 2026US 12,607,641 B2Haemonetics Corporation
- Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration7 Apr 2026US 12,596,125 B2Alcediag
- Clinical decision support system8 Oct 2026US 2026/0309696 A1Instrumentation Laboratory Company
- Methods for Identifying Haemoglobin S or C in a Biological Sample and Kits Thereof8 Oct 2026US 2026/0309726 A1Indian Institute of Science
- Patrolling monocyte cellular therapy1 Oct 2026US 2026/0297525 A1New York Blood Center, Inc.
- Diagnosis method using cell free nucleosome levels24 Sep 2026US 2026/0287594 A1Belgian Volition SRL
- Protein biomarkers for lanadelumab treatment3 Sep 2026US 2026/0259227 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Device, systems and methods for evaluation of hemostasis97US 9,272,280 B2HemoSonics LLC · 2016
- Devices, systems and methods for evaluation of hemostasis74US 9,977,039 B2HemoSonics LLC · 2018
- Devices, systems and methods for evaluation of hemostasis73US 9,410,971 B2HemoSonics LLC · 2016
- Devices, systems and methods for evaluation of hemostasis69US 10,031,144 B2HemoSonics LLC · 2018
- Method for monitoring coagulability and hypercoagulable states55US 7,169,573 B2Oklahoma Medical Research Foundation · 2007